A new government report shines a bright spotlight on the pricing of high-priced medical devices...


A new government report shines a bright spotlight on the pricing of high-priced medical devices with cost variance ranging as much as 50% across different hospitals for the purchases of the same products. The GAO report raises "serious concerns" over the prices hospitals and Medicare pay for medical devices, as well as stoking up Congressional backlash on the issue. Companies that could be impacted by pricing reform include MDT, BAX, COV, SYK, TMO, ISRG, BDX, STJ, EW, BSX, BCR, VAR.

From other sites
Comments (1)
  • Gary Jakacky
    , contributor
    Comments (2946) | Send Message
     
    Here come the Medicops. They are drawn to high profit margins like flies, and for the same reason. Another leading US industry soon to be destroyed, much like pharma.
    3 Feb 2012, 10:24 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs